HealthSilicon Republicabout 15 hours ago
CroíValve adds $20m to Series B, taking round to $36m
1 min read
CroíValve closed a $20m Series B expansion, bringing the total round to $36m and $43m including grants. New investor BGF joined, funding an expanded US and EU clinical study of the Duo Tricuspid Coaptation Valve System. The Trinity College Dublin spin-out treats tricuspid regurgitation with a minimally invasive device.
Level
Hype check
Tap to vote and see what everyone thinks.
